Bone Mineral Density is Reduced in Patients with Crohn's Disease but Not in Patients with Ulcerative Colitis: a Population Based Study

Overview

Journal Gut

Specialty Gastroenterology

Date 1997 Mar 1

PMID 9135518

Citations 63

Authors

J Jahnsen

J A Falch

E Aadland

P Mowinckel

Affiliations

Soon will be listed here.

Abstract

Background: Patients with inflammatory bowel disease are at risk of developing metabolic bone disease.

Aims: To compare bone mineral density in patients with Crohn's disease with patients with ulcerative colitis and healthy subjects, and to evaluate possible risk factors for bone loss in inflammatory bowel disease.

Patients: 60 patients with Crohn's disease, 60 with ulcerative colitis, and 60 healthy subjects were investigated. Each group consisted of 24 men and 36 women.

Methods: Lumbar spine, femoral neck, and total body bone mineral density were measured by dual x ray absorptiometry (DXA), and Z scores were obtained by comparison with age and sex matched normal values.

Results: Mean Z scores were significantly lower in patients with Crohn's disease compared with patients with ulcerative colitis and healthy subjects. Patients with ulcerative colitis had bone mineral densities similar to healthy subjects. Use of corticosteroids, body mass index (BMI), and sex were significant predictor variables for bone mineral density in Crohn's disease. In ulcerative colitis only body mass index and sex were of significant importance. Disease localisation and small bowel resections had no influence on bone mineral density in patients with Crohn's disease.

Conclusions: Patients with Crohn's disease have reduced bone mineral density. Several factors are probably involved, but the reduction is associated with corticosteroid therapy. When studying skeletal effects of inflammatory bowel disease, patients with Crohn's disease and those with ulcerative colitis should be evaluated separately.

Citing Articles

Association between inflammatory bowel disease and osteoporosis in European and East Asian populations: exploring causality, mediation by nutritional status, and shared genetic architecture.

Kang J, Wu X, Li Y, Zhao S, Wang S, Yu D Front Immunol. 2024; 15:1425610.

PMID: 39136019 PMC: 11317921. DOI: 10.3389/fimmu.2024.1425610.

Pivotal Role of Intestinal Microbiota and Intraluminal Metabolites for the Maintenance of Gut-Bone Physiology.

Gruner N, Ortlepp A, Mattner J Int J Mol Sci. 2023; 24(6).

PMID: 36982235 PMC: 10048911. DOI: 10.3390/ijms24065161.

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease-Do We Already Know Everything?.

Lewandowski K, Kaniewska M, Wiecek M, Szwarc P, Panufnik P, Tulewicz-Marti E Nutrients. 2023; 15(5).

PMID: 36904150 PMC: 10005035. DOI: 10.3390/nu15051151.

Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?.

Krela-Kazmierczak I, Szymczak-Tomczak A, Tomczak M, Lykowska-Szuber L, Eder P, Kucharski M Arch Med Sci. 2021; 17(3):662-674.

PMID: 34025836 PMC: 8130475. DOI: 10.5114/aoms.2018.78009.

A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.

Rosano G, Schiefke I, Gohring U, Fabien V, Bonassi S, Stein J J Clin Med. 2020; 9(11).

PMID: 33172157 PMC: 7694774. DOI: 10.3390/jcm9113587.

References

Cummings S, Black D, Nevitt M, Browner W, Cauley J, Ensrud K . Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993; 341(8837):72-5. DOI: 10.1016/0140-6736(93)92555-8. View

Clements D, Motley R, Evans W, Harries A, Rhodes J, Coles R . Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol. 1992; 27(12):1055-60. DOI: 10.3109/00365529209028138. View

Tromm A, Rickels K, Huppe D, Wiebe V, May B . [Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography]. Leber Magen Darm. 1994; 24(1):23-6, 29-30. View

Motley R, Crawley E, Evans C, Rhodes J, Compston J . Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut. 1988; 29(10):1332-6. PMC: 1433993. DOI: 10.1136/gut.29.10.1332. View

Bernstein C, Seeger L, Sayre J, Anton P, Artinian L, Shanahan F . Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res. 1995; 10(2):250-6. DOI: 10.1002/jbmr.5650100211. View

Gut J, Auriche M, Juillet Y . [Critical study of methods of postmarketing drug surveillance]. Therapie. 1985; 40(5):313-9. View

Reid I, Evans M, Wattie D, Ames R, Cundy T . Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients. Osteoporos Int. 1992; 2(2):103-5. DOI: 10.1007/BF01623844. View

Puolijoki H, Liippo K, Herrala J, Salmi J, TALA E . Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic women. Bone. 1992; 13(4):285-8. DOI: 10.1016/8756-3282(92)90072-5. View

Edelstein S, Barrett-Connor E . Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol. 1993; 138(3):160-9. DOI: 10.1093/oxfordjournals.aje.a116842. View

10.

Ross P, Davis J, Epstein R, Wasnich R . Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991; 114(11):919-23. DOI: 10.7326/0003-4819-114-11-919. View

11.

Nielsen H, Charles P, Mosekilde L . The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab. 1988; 67(5):1025-30. DOI: 10.1210/jcem-67-5-1025. View

12.

Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M . Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int. 1995; 5(3):156-60. DOI: 10.1007/BF02106094. View

13.

Silvennoinen J, Karttunen T, Niemela S, Manelius J, Lehtola J . A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995; 37(1):71-6. PMC: 1382771. DOI: 10.1136/gut.37.1.71. View

14.

Cummings S, Black D, Nevitt M, Browner W, Cauley J, Genant H . Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990; 263(5):665-8. View

15.

Hui S, Slemenda C, JOHNSTON Jr C . Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 1989; 111(5):355-61. DOI: 10.7326/0003-4819-111-5-355. View

16.

Falch J, Meyer H . [Bone mineral density measured by dual X-ray absorptiometry. A reference material from Oslo]. Tidsskr Nor Laegeforen. 1996; 116(19):2299-302. View

17.

Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M . Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology. 1995; 108(2):417-22. DOI: 10.1016/0016-5085(95)90068-3. View

18.

Lukert B, Raisz L . Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am. 1994; 20(3):629-50. View

19.

Adler R, Rosen C . Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am. 1994; 23(3):641-54. View

20.

Pigot F, Roux C, Chaussade S, Hardelin D, Pelleter O, du Puy Montbrun T . Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci. 1992; 37(9):1396-403. DOI: 10.1007/BF01296010. View